Drug Delivery
Findings describe new data in drug delivery research
Published in TB and Outbreaks Week, February 28th, 2006
Study 1: Oral solid lipid nanoparticle-based antituberculosis therapy may improve patient compliance.
"The present study was planned to evaluate the chemotherapeutic potential of oral solid lipid nanoparticles (SLNs) incorporating rifampicin, isoniazid, and pyrazinamide against experimental tuberculosis.
"The SLNs were prepared by the 'emulsion solvent diffusion' technique with an encapsulation efficiency of 51±5% for rifampicin, 45±4% for isoniazid and 41±4% for pyrazinamide," investigators in India report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Influenza Vaccines
Influenza vaccine effectiveness estimated during an outbreak - Legionnaires Disease Outbreaks
Community-wide Legionnaires disease outbreak linked to industrial cooling towers - Pertussis Outbreaks
Early pertussis diagnosis may limit transmission and protect susceptible infants - Respiratory Syncytial Virus
Respiratory syncytial virus outbreak occurred in neonatal intensive care unit - Zygomycosis
Zygomycosis is an emerging fungal infection - Acinetobacter Baumannii Outbreaks
Single clone Acinetobacter baumannii strain spreads in Turkey ICU - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
